Table 1 Baseline characteristics of 1735 HBeAg-seronegative patients with genotype B or C chronic hepatitis B virus infection in the REVEAL-HBV cohort.
Characteristics | Number (%) (n = 1735) |
|---|---|
Age | |
30–39 | 507 (29.2) |
40–49 | 528 (30.4) |
50–59 | 528 (30.4) |
60–69 | 172 (9.9) |
Gender | |
Female | 650 (37.5) |
Male | 1085 (62.5) |
Cigarette smoking | |
No | 1171 (67.5) |
Yes | 564 (32.5) |
Alcohol drinkinga | |
No | 1526 (88) |
Yes | 208 (12) |
Body mass index (kg/m2)b | |
< 30 | 1656 (95.6) |
≥ 30 | 77 (4.4) |
Serum alanine aminotransferase level (U/L) | |
< 45 | 1657 (95.5) |
≥ 45 | 78 (4.5) |
HBV genotyped | |
B | 1193 (68.8) |
C | 542 (31.2) |
HBV DNA level (copies/mL) | |
≥ 1,000,000 | 108 (6.2) |
100,000–999,999 | 229 (13.2) |
10,000–99,999 | 453 (26.1) |
300–9999 | 673 (38.8) |
Undetectable | 272 (15.7) |
HBsAg level (IU/mL) | |
≥ 1000 | 766 (44.2) |
100–999 | 621 (35.8) |
< 100 | 348 (20.1) |
